July 29 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS ANNOUNCES MANAGEMENT CHANGE & PRELIMINARY Q2 FINANCIAL HIGHLIGHTS
* CIPHER PHARMACEUTICALS INC - CRAIG MULL HAS BEEN NAMED INTERIM CHIEF EXECUTIVE OFFICER OF CIPHER, REPLACING ROBERT TESSAROLO
* CIPHER PHARMACEUTICALS INC - CO HAS COMMENCED A FORMAL SEARCH PROCESS FOR A NEW CHIEF EXECUTIVE OFFICER
* CIPHER PHARMACEUTICALS INC - EXPECTS Q2 2019EARNINGS PER SHARE IN RANGE OF $0.04 TO $0.05
* CIPHER PHARMACEUTICALS INC - SEES Q2 2019 REVENUE IN RANGE OF $5.4 MILLION TO $5.6 MILLION, COMPARED WITH $6.95 MILLION IN Q2 2018